GO:0055085 transmembrane transport: Mechanism, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0055085 transmembrane transport is the biological process by which a solute is moved across a lipid bilayer from one side of a membrane to the other.
Transport can be passive or active, and many transporters couple substrate movement to ATP hydrolysis or ion gradients.
Transporter proteins undergo conformational changes that can now be captured in motion, revealing dynamic transport mechanisms.
Membrane lipid composition strongly influences protein-mediated transmembrane transport.
Transmembrane transport is central to drug delivery, nutrient uptake, ion homeostasis, and cellular signaling.
Bioinformatic and structural approaches are essential for classifying and predicting transporter function.

Description

Transmembrane transport (GO:0055085) is a fundamental biological process in which a solute is transported across a lipid bilayer, from one side of a membrane to the other. This process is essential for maintaining cellular homeostasis, nutrient acquisition, waste removal, and signal transduction. Transporters are integral membrane proteins that facilitate the movement of ions, metabolites, drugs, and water across biological membranes. The importance of transmembrane transport extends to pharmacology, as many drugs rely on transporter-mediated delivery to reach their targets. Recent advances in structural biology and biophysics have enabled researchers to capture transport in motion, providing unprecedented insights into the conformational dynamics of transporter proteins. Understanding the molecular mechanisms, regulation, and disease relevance of transmembrane transport is critical for developing new therapeutic strategies and for interpreting genomic and proteomic data.

transmembrane transport At A Glance

GO ID GO:0055085
GO term transmembrane transport
Ontology biological_process
Synonym ATP hydrolysis coupled transmembrane transport; membrane transport
Major function Movement of solutes across lipid bilayers
Definition The process in which a solute is transported across a lipid bilayer, from one side of a membrane to the other.
Related processes Ion transport, drug transport, nutrient uptake, water transport
Key protein families ABC transporters, SLC transporters, ATPases, aquaporins
Research relevance Drug delivery, disease mechanisms, membrane biophysics

What Is GO:0055085?

According to the Gene Ontology, transmembrane transport (GO:0055085) is the process in which a solute is transported across a lipid bilayer, from one side of a membrane to the other. This definition encompasses both passive and active transport mechanisms, including ATP hydrolysis coupled transmembrane transport and membrane transport. The process requires a membrane-spanning transport protein or complex that facilitates the movement of specific solutes, often against their concentration gradient, using energy from ATP or ion gradients.

Why Is transmembrane transport Important in Cell Biology?

Transmembrane transport is essential for virtually all cellular functions, from nutrient uptake and waste removal to signal transduction and maintenance of ion gradients. Dysregulation of transporters is linked to numerous diseases, including cancer, neurological disorders, and metabolic diseases. Moreover, many pharmacological agents depend on transporters for their absorption, distribution, and excretion, making transmembrane transport a critical area of study in drug development.
Maintains cellular homeostasis by regulating ion and metabolite concentrations.
Enables nutrient uptake and waste removal across membranes.
Plays a key role in drug absorption, distribution, and targeting.
Involved in signal transduction and cellular communication.
Dysfunction is associated with cancer, neurodegeneration, and metabolic disorders.
Membrane lipid composition modulates transporter activity.
Bioinformatic tools help classify and predict transporter function.
Structural dynamics of transporters can be studied using advanced biophysical methods.
Transmembrane transport is a target for therapeutic intervention.
Understanding transport mechanisms aids in designing better drugs.

What Happens During transmembrane transport?

Substrate recognition and binding
In simple terms: The transporter first grabs the molecule it needs to move.
Transporters possess specific binding sites that recognize and bind their substrates with high affinity. This initial step ensures selectivity and is often regulated by conformational states of the transporter. Local attraction of substrates and co-substrates can enhance weak acid and base transmembrane transport.
Conformational changes and translocation
In simple terms: The transporter changes shape to carry the molecule across the membrane.
Upon substrate binding, transporters undergo a series of conformational changes that move the substrate from one side of the membrane to the other. Recent studies have captured these motions, revealing elevator-type mechanisms in transporters such as UapA, where transmembrane helices 5 and 12 control transport dynamics, substrate affinity, and specificity.
Energy coupling and driving forces
In simple terms: Some transporters use energy to push molecules against their gradient.
Active transporters couple substrate movement to energy sources such as ATP hydrolysis or ion gradients. ATP hydrolysis coupled transmembrane transport is a synonym for this process, highlighting the role of energy in driving transport. The lipid environment can influence the energetics of transport.
Release and resetting
In simple terms: The molecule is released on the other side, and the transporter resets.
After translocation, the substrate is released into the opposite compartment, and the transporter returns to its initial conformation to begin another cycle. This resetting step is crucial for continuous transport and can be regulated by cellular signals.
Regulation and modulation
In simple terms: Cells can adjust transport activity based on their needs.
Transmembrane transport is regulated at multiple levels, including gene expression, post-translational modifications, and interaction with lipids. For example, membrane lipid composition can modulate protein-mediated transport. Additionally, local substrate availability and co-substrate attraction can enhance transport efficiency.

Key Genes Involved in GO:0055085 transmembrane transport

The following genes and proteins are representative examples of molecules involved in transmembrane transport, based on published literature.
GeneMajor RoleResearch Relevance
ABCB1ATP-binding cassette transporter; drug effluxMultidrug resistance in cancer
SLC2A1Glucose transporterNutrient uptake; metabolic studies
ATP1A1Na+/K+-ATPase; ion transportIon homeostasis; neurological disorders
AQP1Water channelWater transport; corneal endothelium
SLC12A2Na-K-Cl cotransporterIon transport; kidney function
CFTRChloride channelCystic fibrosis; ion transport
SLC6A4Serotonin transporterNeurotransmission; drug targeting
SLC22A1Organic cation transporterDrug transport; pharmacokinetics
ABCG2ABC transporter; urate effluxGout; drug resistance
SLC7A11Cystine/glutamate antiporterRedox balance; cancer
ATP2B1Plasma membrane Ca2+-ATPaseCalcium signaling
SLC9A1Na+/H+ exchangerpH regulation; cell proliferation
UapAUric acid-xanthine transporterModel for elevator-type transport
SLC4A1Anion exchangerRed blood cell function
SLC16A1Monocarboxylate transporterLactate transport; cancer metabolism
SLC25A1Mitochondrial citrate carrierMetabolic regulation
SLC1A2Glutamate transporterNeurotransmission; excitotoxicity

How Is transmembrane transport Regulated?

Transmembrane transport is regulated by diverse mechanisms, including transcriptional control, post-translational modifications, and interactions with membrane lipids. For instance, the lipid environment can influence the conformational dynamics and activity of transporters. Local substrate and co-substrate attraction can enhance weak acid and base transport. Additionally, transporters can be regulated by phosphorylation and other modifications that alter their trafficking or activity.

transmembrane transport and Human Disease

GeneDisease / BiologyPotential Experimental Model
ABCB1Multidrug resistance in cancerKnockout in cancer cell lines; drug sensitivity assays
CFTRCystic fibrosisKnock-in of patient mutations; chloride transport assays
SLC6A4Depression; anxietyKnockout mice; behavioral tests
SLC2A1GLUT1 deficiency syndromePoint mutation knock-in; glucose uptake assays
AQP1Corneal edemaKnockout in corneal endothelial cells; water transport assays
Transmembrane transport in cancer
Altered expression of transporters such as ABCB1 and SLC7A11 contributes to drug resistance and metabolic reprogramming in cancer cells. Transporter-mediated drug delivery is a key consideration in chemotherapy.
Transmembrane transport in neurological disorders
Dysfunctional ion channels and neurotransmitter transporters, such as SLC6A4 and SLC1A2, are implicated in depression, epilepsy, and neurodegeneration. Proper ion homeostasis is critical for neuronal function.
Transmembrane transport in metabolic and renal diseases
Transporters in the kidney and intestine regulate nutrient and drug absorption. Mutations in SLC transporters can cause metabolic disorders and renal dysfunction.
Transmembrane transport in corneal endothelium
Water and urea transport in corneal endothelial cells is essential for corneal transparency. Aquaporins and urea transporters play key roles in this process.

From transmembrane transport-Related Genes to Experimental Models

Research QuestionSuitable Model
Does gene X directly transport substrate Y?Knockout cell line + transport assay
What is the effect of a disease-associated point mutation on transport?Point mutation knock-in cell line
Can we visualize transporter localization?Tagged knock-in (e.g., GFP) cell line
Does overexpression of transporter increase drug resistance?Overexpression cell line + cytotoxicity assay
What is the role of transporter in vivo?Knockout mouse model
Can we screen for novel transport inhibitors?CRISPR library screening in transport-competent cells

How to Study the transmembrane transport Process

MethodWhat It MeasuresTypical Application
Radiolabeled uptake assayTransport rate and substrate specificityCharacterizing novel transporters
Patch clampIon channel activityElectrophysiology of ion channels
Cryo-EMHigh-resolution structureConformational states of transporters
FRETConformational dynamicsReal-time transport motions
RNA-seqTransporter gene expressionTissue-specific expression profiling
ProteomicsTransporter protein abundanceMembrane proteome analysis
CRISPR screenGenes affecting transportDiscovery of transport regulators
Molecular dynamicsSimulated transport processMechanistic insights into transport
Transport assays
Radiolabeled or fluorescent substrate uptake assays measure transport activity in cells or vesicles. These are fundamental for characterizing transporter function.
Structural biology and biophysics
Cryo-EM, X-ray crystallography, and single-molecule FRET capture conformational changes during transport, revealing dynamic mechanisms.
Bioinformatics and genomics
Genomic and transcriptomic analyses identify transporter genes and predict their function. Bioinformatic study of transmembrane molecular transport helps classify families and substrates.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate or mediate transmembrane transport, enabling discovery of new transporters and regulators.

How CRISPR Can Be Used to Study GO:0055085 transmembrane transport

Knockout

CRISPR knockout of transporter genes in cell lines or animal models can abolish transport activity, allowing researchers to study loss-of-function phenotypes and validate substrate specificity.

Point Mutation

Introducing disease-associated point mutations into transporter genes via CRISPR knock-in enables functional studies of altered transport kinetics and drug responses.

Knock-in

Tagged knock-in (e.g., GFP or HA) allows visualization and purification of transporters, facilitating localization and interaction studies.

Overexpression

CRISPR activation or cDNA overexpression can increase transporter levels, useful for studying drug resistance, substrate flux, and screening for inhibitors.

How EDITGENE Supports transmembrane transport Research

Researchers studying transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in transport, how mutations affect function, and what therapeutic potential it holds. EDITGENE provides comprehensive CRISPR-based services to address these questions with precision and scale.
Contact EDITGENE today to design your custom CRISPR model for transmembrane transport research.

Frequently Asked Questions About transmembrane transport

Transmembrane transport (GO:0055085) is the process in which a solute is transported across a lipid bilayer, from one side of a membrane to the other.
Genes encoding transporters such as ABCB1, SLC2A1, ATP1A1, AQP1, and CFTR are key players in transmembrane transport.
It is regulated by gene expression, post-translational modifications, and membrane lipid composition.
Cancer, neurological disorders, metabolic diseases, and cystic fibrosis are linked to transporter dysfunction.
Transport assays, structural biology, bioinformatics, and CRISPR screening are commonly used.
Yes, CRISPR knockout, knock-in, and overexpression models enable functional studies of transporters.
Lipids can modulate transporter conformation and activity, influencing transport efficiency.
Specific binding sites and conformational changes ensure selective transport of substrates.
It is a synonym for active transport where ATP hydrolysis provides energy for solute movement.
Many drugs rely on transporters for cellular uptake and efflux, affecting efficacy and resistance.

Conclusion

Transmembrane transport (GO:0055085) is a cornerstone of cellular physiology, enabling the movement of solutes across membranes. Its dysregulation underlies numerous diseases, and it is a major target for therapeutic intervention. Advances in structural biology, bioinformatics, and CRISPR technologies continue to illuminate the mechanisms and regulation of this essential process.

References

  1. 1. Loland CJ et al.. 2024. Transmembrane transporter proteins: Capturing transport in motion.. Basic Clin Pharmacol Toxicol 134(2):203-205 PMID: 37945540
  2. 2. Epalle NH et al.. 2022. Local Attraction of Substrates and Co-Substrates Enhances Weak Acid and Base Transmembrane Transport.. Biomolecules 12(12) PMID: 36551222
  3. 3. Katkova LE et al.. 2025. Transmembrane Transport of Water and Urea in Rat Corneal Endothelial Cells.. Biochemistry (Mosc) 90(10):1366-1375 PMID: 41176795
  4. 4. Gyimesi G et al.. 2023. Transporter-Mediated Drug Delivery.. Molecules 28(3) PMID: 36770817
  5. 5. Dimakis D et al.. 2022. Transmembrane helices 5 and 12 control transport dynamics, substrate affinity, and specificity in the elevator-type UapA transporter.. Genetics 222(1) PMID: 35894659
  6. 7. Denning EJ et al.. 2013. Influence of lipids on protein-mediated transmembrane transport.. Chem Phys Lipids 169:57-71 PMID: 23473882
  7. 8. Saier MH Jr et al.. 2006. The bioinformatic study of transmembrane molecular transport.. J Mol Microbiol Biotechnol 11(6):289-90 PMID: 17114892
Contact Us
*
*
*
*
How did you hear about us: